Patrick Ott

Dr. Patrick Ott is an Associate Professor of Medicine at Harvard Medical School and holds leadership roles as Clinical Director of the Melanoma Disease Center and Director of Clinical Sciences at the Center for Immuno-Oncology at Dana-Farber Cancer Institute. His clinical expertise focuses on immunotherapy and melanoma, supported by board certifications in Hematology (2008), Internal Medicine (2005), and Medical Oncology (2008).

• Education: Medical School - Ludwig Maximilians University of Munich; Residency - Case Western Reserve University; Fellowship - New York University School of Medicine

Research interests emphasize advancing immuno-oncology therapies, particularly in melanoma and kidney cancer. Recent work includes groundbreaking cancer vaccine trials for stage III/IV kidney cancer. Recognized as one of the world's most highly cited researchers in 2024.

Leads multidisciplinary teams in clinical trials and translational research, with a focus on bridging laboratory discoveries to patient care. Active in global oncology initiatives and maintains a patient-centered approach emphasized in 200+ verified patient testimonials praising his compassionate care and innovative treatments.